[go: up one dir, main page]

DE69400798T2 - Urethane und Urea zur Induktion der Cytokin-Produktion - Google Patents

Urethane und Urea zur Induktion der Cytokin-Produktion

Info

Publication number
DE69400798T2
DE69400798T2 DE69400798T DE69400798T DE69400798T2 DE 69400798 T2 DE69400798 T2 DE 69400798T2 DE 69400798 T DE69400798 T DE 69400798T DE 69400798 T DE69400798 T DE 69400798T DE 69400798 T2 DE69400798 T2 DE 69400798T2
Authority
DE
Germany
Prior art keywords
group
carboxy
substituted
unsubstituted
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69400798T
Other languages
German (de)
English (en)
Other versions
DE69400798D1 (de
Inventor
Semiramis Ayral-Kaloustian
Mila T Du
James J Gibbons
Steven R Schow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE69400798D1 publication Critical patent/DE69400798D1/de
Application granted granted Critical
Publication of DE69400798T2 publication Critical patent/DE69400798T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69400798T 1993-05-12 1994-04-20 Urethane und Urea zur Induktion der Cytokin-Produktion Expired - Fee Related DE69400798T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/063,174 US5312831A (en) 1993-05-12 1993-05-12 Urethanes and ureas that induce cytokine production

Publications (2)

Publication Number Publication Date
DE69400798D1 DE69400798D1 (de) 1996-11-28
DE69400798T2 true DE69400798T2 (de) 1997-03-13

Family

ID=22047440

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69400798T Expired - Fee Related DE69400798T2 (de) 1993-05-12 1994-04-20 Urethane und Urea zur Induktion der Cytokin-Produktion

Country Status (26)

Country Link
US (6) US5312831A (sk)
EP (1) EP0652228B1 (sk)
JP (1) JP3583469B2 (sk)
KR (1) KR100296543B1 (sk)
CN (1) CN1094943C (sk)
AT (1) ATE144533T1 (sk)
AU (1) AU669064B2 (sk)
CA (1) CA2123261A1 (sk)
CZ (1) CZ290445B6 (sk)
DE (1) DE69400798T2 (sk)
DK (1) DK0652228T3 (sk)
ES (1) ES2094004T3 (sk)
FI (1) FI942186L (sk)
GR (1) GR3022253T3 (sk)
HU (1) HU219768B (sk)
IL (1) IL109602A (sk)
NO (1) NO311223B1 (sk)
NZ (1) NZ260507A (sk)
PH (1) PH30182A (sk)
PL (1) PL179984B1 (sk)
RU (1) RU2135515C1 (sk)
SG (1) SG43071A1 (sk)
SI (1) SI0652228T1 (sk)
SK (1) SK281120B6 (sk)
TW (1) TW380129B (sk)
ZA (1) ZA943266B (sk)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007183A3 (fr) * 1993-06-18 1995-04-18 Solvay Ureines derivees d'alpha, omega-diaminoacides et procede pour leur preparation.
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
TR199802695T2 (xx) 1996-06-27 1999-04-21 Smithkline Beecham Corporation IL-8 Resept�r kar��tlar�
AU3409197A (en) * 1996-06-27 1998-01-14 Smithkline Beecham Corporation Il-8 receptor antagonists
EP0939634A4 (en) * 1996-08-15 2001-02-21 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
CN1305846C (zh) * 1998-03-26 2007-03-21 参天制药株式会社 脲衍生物
US7465754B1 (en) 1999-09-15 2008-12-16 Wyeth Method of potentiating chemotherapy and treating solid tumors
BRPI0308606B8 (pt) * 2002-03-22 2021-05-25 Eisai Co Ltd compostos derivados de hemiasterlina e composição farmacêutica compreendendo os mesmos
US7332158B2 (en) * 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
AR041834A1 (es) * 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
US20060057121A1 (en) * 2004-09-10 2006-03-16 Demao Yang Compositions and treatments using ex vivo activated cells for myelosuppressed patients
RU2008145871A (ru) * 2006-04-21 2010-05-27 Смитклайн Бичам Корпорейшн (US) Антагонисты рецептора il-8
JP5269763B2 (ja) * 2006-04-21 2013-08-21 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Ｉｌ−８受容体アンタゴニスト
CL2007001829A1 (es) * 2006-06-23 2008-01-25 Smithkline Beecham Corp P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
EP2830439B1 (en) 2012-03-30 2020-11-04 Givaudan SA N-acyl-gaba derivatives for the improvement of the flavour profile of edible compositions
WO2013149025A1 (en) * 2012-03-30 2013-10-03 Givaudan, S., A. N-acyl serine derivatives as food flavouring compounds
SG11201405188XA (en) 2012-03-30 2014-11-27 Givaudan Sa N-acyl-amino acid derivatives as food flavouring compounds, powder compositions|containing them
CN104254253B (zh) 2012-03-30 2017-12-29 奇华顿股份有限公司 作为食品加香化合物的n‑酰化甲硫氨酸衍生物
EP2830441B1 (en) 2012-03-30 2019-11-13 Givaudan SA N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds
JP6209588B2 (ja) 2012-03-30 2017-10-04 ジボダン エス エー 食品フレーバー付与化合物としてのｎ−アシルプロリン誘導体
WO2013148997A1 (en) 2012-03-30 2013-10-03 Givaudan, S.A. N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds
JP6250029B2 (ja) 2012-03-30 2017-12-20 ジボダン エス エー 食品フレーバー付与化合物としてのｎ−アシル−アミノ酸誘導体
EP3057448B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
GB201317424D0 (en) * 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
WO2015050536A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
WO2015050538A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
CN105658089B (zh) 2013-10-02 2019-07-09 奇华顿股份有限公司 有机化合物
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
US20160227825A1 (en) 2013-10-02 2016-08-11 Givaudan Sa Organic Compounds having Taste-Modifying Properties
WO2015048990A1 (en) 2013-10-02 2015-04-09 Givaudan Sa Organic compounds having taste-modifying properties
EP3672939A1 (en) 2017-08-21 2020-07-01 Celgene Corporation Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
CN109601739B (zh) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 一种复合氨基酸饲料添加剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4349466A (en) * 1978-11-14 1982-09-14 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
ES8604609A1 (es) * 1985-07-02 1986-02-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 1-(n-(1(r,s)-(etoxi- carbonil)-3-fenilpropil)-l-alanil)-l-prolina
ATE174794T1 (de) * 1991-09-27 1999-01-15 Univ Texas Parenteral anzuwendende aminosäuren enthaltende zubereitungen zur bekämpfung von hypotension und verwandten pathologien

Also Published As

Publication number Publication date
FI942186A7 (fi) 1994-11-13
HU219768B (hu) 2001-07-30
US5312831A (en) 1994-05-17
SK49194A3 (en) 1995-02-08
IL109602A0 (en) 1994-08-26
US5545662A (en) 1996-08-13
US5602275A (en) 1997-02-11
JPH07179414A (ja) 1995-07-18
DK0652228T3 (da) 1996-11-25
CN1100413A (zh) 1995-03-22
NZ260507A (en) 1996-02-27
PL179984B1 (pl) 2000-11-30
HUT67038A (en) 1995-01-30
US5658945A (en) 1997-08-19
ES2094004T3 (es) 1997-01-01
DE69400798D1 (de) 1996-11-28
IL109602A (en) 2000-06-01
SG43071A1 (en) 1997-10-17
CN1094943C (zh) 2002-11-27
EP0652228A1 (en) 1995-05-10
US5633280A (en) 1997-05-27
FI942186L (fi) 1994-11-13
TW380129B (en) 2000-01-21
CZ290445B6 (cs) 2002-07-17
AU6304394A (en) 1994-11-17
SK281120B6 (sk) 2000-12-11
GR3022253T3 (en) 1997-04-30
NO311223B1 (no) 2001-10-29
NO941786D0 (no) 1994-05-11
US5616612A (en) 1997-04-01
CA2123261A1 (en) 1994-11-13
FI942186A0 (fi) 1994-05-11
HU9401444D0 (en) 1994-08-29
EP0652228B1 (en) 1996-10-23
NO941786L (no) 1994-11-14
ZA943266B (en) 1995-01-12
SI0652228T1 (en) 1997-10-31
RU2135515C1 (ru) 1999-08-27
CZ98194A3 (en) 1994-12-15
JP3583469B2 (ja) 2004-11-04
ATE144533T1 (de) 1996-11-15
AU669064B2 (en) 1996-05-23
KR100296543B1 (ko) 2001-11-22
PH30182A (en) 1997-01-21

Similar Documents

Publication Publication Date Title
DE69400798T2 (de) Urethane und Urea zur Induktion der Cytokin-Produktion
DE69434136T2 (de) Dolastatin-derivate
EP1523493B1 (de) Neue tubulysinanaloga
EP0384362A2 (de) Glycinderivate
EP0372486A2 (de) Neue Benzoesäure- und Phenylessigsäurederivate, ihre Herstellung und Verwendung als Heilmittel
DE3783280T2 (de) Teilweise retro-invertierte analoge des tuftsin, methode zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
EP0026464A2 (de) Peptide, deren Herstellung, deren Verwendung und pharmazeutische Präparate
DE3508251A1 (de) Dipeptide
AU762691C (en) Hemiasterlin analogs
EP0688314B1 (de) Prodrug-derivate von enzyminhibitoren mit hydroxylgruppen, verfahren zu deren herstellung und ihre verwendung
DE4331135A1 (de) Neue antiviral wirksame valinhaltige Pseudopeptide
DE4331134A1 (de) Neue antiviral wirksame Pseudopeptide
EP0611776A2 (de) Neue antiviral wirksame Pseudopeptide
DE69620627T2 (de) Polyfluoralkyl-tryptiphan tripeptid thrombin hemmer
EP2051992B1 (de) Verfahren zur herstellung von kondensationsprodukten aus n-substituierten glycinderivaten (peptoide) über sequentielle ugi-mehrkomponentenreaktionen
DE60015931T2 (de) Verfahren zur herstellung eines chiralen-beta-aminosäureesters
DE69018268T2 (de) Verfahren zur herstellung von geschützten aza-yperiten prodrugs.
DE69118784T2 (de) Neue Peptidderivate und deren pharmazeutischer Gebrauch
DE69313842T2 (de) Teilweise modifizierte und retro-invertierte tetrapeptides analogue von fragmenten des c reaktiven proteins
DE68909451T2 (de) Peptide mit inhibitorischer Wirkung auf enzymatische Systeme, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DD215539A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinderivate
DD280764A5 (de) Verfahren zur herstellung von peptid-immunistimulantien
HU188110B (en) Process for producing new tripeptide-derivatives
DE4321502A1 (de) Alkinol-substituierte Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung als antiretrovirale Mittel
DE4307438A1 (de) Neue antiviral wirksame Pseudopeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US

8339 Ceased/non-payment of the annual fee